Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
CRBP Corbus Pharmaceuticals
- 15.0800
- 0.00000.00%
Close Dec 13 16:00 ET
- 15.0800
- 0.00000.00%
Post 20:01 ET
183.67MMarket Cap-3.20P/E (TTM)
15.2000High14.8500Low233.47KVolume15.0000Open15.0800Pre Close3.51MTurnover3.01%Turnover RatioLossP/E (Static)12.18MShares61.900052wk High1.22P/B116.99MFloat Cap5.087752wk Low--Dividend TTM7.76MShs Float323.4000Historical High--Div YieldTTM2.32%Amplitude2.1100Historical Low15.0200Avg Price1Lot Size
About Corbus Pharmaceuticals Company
Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF? expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.
Company Profile
SymbolCRBP
Company NameCorbus Pharmaceuticals
Listing DateApr 16, 2015
Founded2009
CEODr. Yuval Cohen, PhD
MarketNASDAQ
Employees19
Fiscal Year Ends12-31
Address500 River Ridge Drive,Second floor
CityNorwood
ProvinceMassachusetts
CountryUnited States of America
Zip Code02062
Phone1-617-963-0100
Websitehttp://www.corbuspharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Yuval Cohen, PhD
- Chief Executive Officer and Director
- 1.14M
- Sean F. Moran, C.P.A.,M.B.A.
- Chief Financial Officer and Principal Accounting Officer
- 717.26K
- Alan F. Holmer
- Chairman of the Board
- 120.66K
- Dr. Yong Ben, M.D.
- Independent Director
- 94.21K
- Dr. Anne Altmeyer, M.P.H.,PhD
- Independent Director
- 90.51K
- Rachelle S. Jacques
- Independent Director
- 104.42K
- Dr. John K. Jenkins, M.D.
- Independent Director
- 109.74K
- Winston Kung, M.B.A.
- Independent Director
- --
- Dr. Peter Salzmann, M.B.A.,M.D.
- Independent Director
- 89.41K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.